Serum metabolomics uncovering specific metabolite signatures of intra- and extrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Serum metabolomics uncovering specific metabolite signatures of intra- and extrahepatic cholangiocarcinoma

Published:2016 Issue:2 Volume:12 Page:334-340
ISSN:1742-206X
Container-title:Molecular BioSystems
language:en
Short-container-title:Mol. BioSyst.

Author:

Liang Qun¹²³⁴⁵,Liu Han⁶⁷⁸,Zhang Tianyu¹²³⁴⁵,Jiang Yan¹²³⁴⁵,Xing Haitao¹²³⁴⁵,Zhang Hua¹²³⁴⁵

Affiliation:

1. ICU Center

2. First Affiliated Hospital

3. School of Pharmacy

4. Heilongjiang University of Chinese Medicine

5. Harbin 150040

6. Simon Fraser University (SFU)

7. Burnaby

8. Canada

Abstract

There is a lack of diagnostic tests for cholangiocarcinoma. This report identifies 4 serum metabolites which could differentiate cholangiocarcinoma patients with high accuracy.

Publisher

Royal Society of Chemistry (RSC)

Subject

Molecular Biology,Biotechnology

Link

http://pubs.rsc.org/en/content/articlepdf/2016/MB/C5MB00572H

Reference21 articles.

1. Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2

2. Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma

3. Identification of Cellular Targets in Human Intrahepatic Cholangiocarcinoma Using Laser Microdissection and Accurate Mass and Time Tag Proteomics

4. Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk

5. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics for searching validated biomarkers in cancer studies: a decade in review;Expert Review of Molecular Diagnostics;2024-06-21

2. Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review;Cancer Epidemiology, Biomarkers & Prevention;2023-07-06

3. Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer;JHEP Reports;2023-03

4. The Role of Purine Metabolism-Related Genes PPAT and IMPDH1 in the Carcinogenesis of Intrahepatic Cholangiocarcinoma Based on Metabonomic and Bioinformatic Analyses;Journal of Oncology;2023-01-20

5. Molecular diagnostics and biomarkers in cholangiocarcinoma;Surgical Oncology;2022-09